NCT06096779 2026-03-06
Kirros
Genentech, Inc.
Phase 2 Recruiting
Clinical Trials
48 trialsNCT05953337 2026-03-04
Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)
ABK Biomedical
Phase NA Active not recruiting
NCT05063565 2026-03-02
ROWAN
Boston Scientific Corporation
Phase 2 Active not recruiting
NCT07377487 2026-02-20
INDIGO
Boston Scientific Corporation
Phase NA Recruiting
NCT06600321 2026-02-17
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Alnylam Pharmaceuticals
Phase 1 Recruiting
NCT04618692 2025-12-18
Biliary Anastomosis Using Surgical Loupe Versus Microscope in Living Donor Liver Transplantation
Istanbul Medipol University Hospital
Phase NA Completed
NCT07191548 2025-10-10
LIVERMET-IRE
Angiodynamics, Inc.
Phase NA Not yet recruiting
NCT04727307 2025-09-30
AB-LATE02
University Hospital, Montpellier
Phase 2 Recruiting
NCT07111130 2025-09-23
RE-BALANCE
National Cancer Centre, Singapore
Phase NA Not yet recruiting
NCT07185360 2025-09-22
LIVER-TRACK
Assistance Publique - HĂ´pitaux de Paris
Phase NA Not yet recruiting
NCT07150624 2025-09-02
The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine
Anhui Provincial Hospital
Phase 4 Recruiting
NCT02312817 2025-07-15
RCT of Screening Strategies Among Patients at High Risk for Developing HCC in a Safety-net Health System
University of Texas Southwestern Medical Center
Phase NA Completed
NCT07053488 2025-07-08
CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
Phase 1/2 Recruiting
NCT04926376 2024-11-29
Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)
ABK Biomedical
Phase NA Completed
NCT06061276 2024-09-23
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
Sun Yat-sen University
Phase NA Recruiting
NCT02301104 2024-09-05
A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment
Taiho Oncology, Inc.
Phase 1 Completed
NCT02112656 2024-08-20
OPTIMA
Imunon
Phase 3 Completed
NCT04518852 2024-06-25
TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC
Sichuan Cancer Hospital and Research Institute
Phase 2 Completed
NCT02508467 2024-04-12
A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma
Blueprint Medicines Corporation
Phase 1 Completed
NCT04172714 2022-12-06
Low-dose Y90 Treatment Planning for HCC
Emory University
Phase NA Completed
NCT04825470 2022-03-11
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Phase NA Unknown
NCT02292173 2021-06-10
Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00543777 2021-04-13
Magnetic Resonance Elastography and 2-Point Dixon MR Imaging Techniques in Diffuse Liver Disease
M.D. Anderson Cancer Center
Phase 1/2 Completed
NCT03008512 2021-02-04
A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib
Gachon University Gil Medical Center
Phase 2 Terminated
NCT04640116 2020-12-19
TIPS Combined With Microwave Ablation in HCC Patients With Refractory Ascites
Sun Yat-sen University
Phase NA Unknown
NCT01871545 2020-07-09
Evaluation of Liver Cancer With Magnetic Resonance Imaging (MRI)
Icahn School of Medicine at Mount Sinai
Phase NA Completed
NCT02989870 2020-06-05
Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Withdrawn
NCT03811431 2019-01-22
ConCLUDe
Iuliu Hatieganu University of Medicine and Pharmacy
Phase NA Unknown
NCT03620916 2018-10-04
Comparison of Intrathecal and Intravenous Analgesia in Patients Undergoing Liver Resection
Medical University of Warsaw
Phase NA Unknown
NCT01177007 2017-08-28
Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors
Yale University
Phase 2 Completed
NCT02208804 2016-11-09
SIM
UMC Utrecht
Phase 2/3 Unknown
NCT02758977 2016-05-03
ALPPSforCRLM
University of Zurich
Phase NA Unknown
NCT00827554 2016-04-01
The Role of Low Molecular Weight Heparins in Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital
Phase 2/3 Completed
NCT00874224 2016-03-09
ORANGE II
Maastricht University Medical Center
Phase NA Completed
NCT01567631 2016-02-01
LAHIGA
Southwest Hospital, China
Phase NA Unknown
NCT02647047 2016-01-06
Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery
Ospedale San Raffaele
Phase NA Unknown
NCT00627042 2014-10-08
Study of IMC-1121B (Ramucirumab) in Participants With Liver Cancer Who Have Not Previously Been Treated With Chemotherapy
Eli Lilly and Company
Phase 2 Completed
NCT01215565 2014-03-13
Fibrolam
Assistance Publique - HĂ´pitaux de Paris
Phase 2 Terminated
NCT02074202 2014-02-28
To Evaluate the Efficacy and Safety of (18F-FCH) Comparing With (18F-FDG) for Detecting Hepatocellular Carcinoma
National Taiwan University Hospital
Phase 3 Unknown
NCT00152607 2013-09-27
Orthotopic Liver Transplantation Using a Living Donor
University of Chicago
Phase 4 Terminated
NCT01394497 2013-02-18
Use of N-Acetylcysteine During Liver Procurement
Azienda Ospedaliera di Padova
Phase 2 Completed
NCT01009593 2012-09-10
Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Abbott
Phase 3 Terminated
NCT01423708 2012-07-18
EPOCAL
Azienda Ospedaliera di Padova
Phase 2 Unknown
NCT01556815 2012-04-25
Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT00969410 2012-04-12
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
AVEO Pharmaceuticals, Inc.
Phase 1 Completed
NCT01533324 2012-02-15
S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC)
Second Military Medical University
Phase 2 Unknown
NCT00526331 2012-01-16
Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy
M.D. Anderson Cancer Center
Phase 4 Completed
NCT00222664 2005-09-22
Qidong Hepatitis B Intervention Study
University of Oxford
Phase 4 Completed